Evidence map›Paper›PMID 36595882›Full record

ArticleSTAR protocols2022

Protocol to identify drug-binding sites in proteins using solution NMR spectroscopy.

Srinivasa Penumutchu, Jiuyang Liu, Upendra K Singh, Tatiana G Kutateladze, Yi Zhang

Open access · goldAbstract read
In one paragraph

Article in STAR protocols, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.3field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 3 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Srinivasa PenumutchuDepartment of Biochemistry, Case Western Reserve University, Cleveland, OH 44106, USA.
Jiuyang LiuDepartment of Pharmacology, University of Colorado School of Medicine, Aurora, CO 80045, USA.
Upendra K SinghDepartment of Biochemistry, Case Western Reserve University, Cleveland, OH 44106, USA.
Tatiana G KutateladzeDepartment of Pharmacology, University of Colorado School of Medicine, Aurora, CO 80045, USA.
Yi ZhangDepartment of Biochemistry, Case Western Reserve University, Cleveland, OH 44106, USA; Case Comprehensive Cancer Center, School of Medicine, Case Western Reserve University, Cleveland, OH 44106, USA. Electronic address: yi.zhang26@case.edu.
Case Western Reserve University · USUniversity of Colorado Denver · US

Funding

Targeting acetylated histone H4 by MLL4R01AG067664 · NIA · UNIVERSITY OF COLORADO DENVER · PI KUTATELADZE, TATIANA G · 2021 to 2025
$2.1M
p62 in Cancer: Mechanism and RegulationR00CA241301 · NCI · CASE WESTERN RESERVE UNIVERSITY · PI ZHANG, YI · 2021 to 2023
$747k
NCI NIH HHS R00 CA241301NIA NIH HHS R01 AG067664
6 · The paper itself

Abstract

Dusquetide is a next-generation IDR (innate defense regulator) targeting the major autophagy receptor protein SQSTM1/p62 and modulating the innate immune response. Here, we describe a protocol for determining dusquetide-binding sites of p62 by solution NMR spectroscopy. Step-by-step technique details were provided, including sample preparation, NMR experiment setup, data processing, and binding site analysis. This protocol could be applied to characterize other small molecules targeting the ZZ domain of p62 (9 kDa) or other proteins containing ZZ domains. For complete details on the use and execution of this protocol, please refer to Zhang et al. (2022).

Indexed as

Immunity, InnateBinding SitesMagnetic Resonance SpectroscopyProtein DomainsSequestosome-1 ProteinSequestosome-1 ProteinMolecular BiologyNMRProtein BiochemistryProtein expression and purification

Identifiers

PMID36595882
PMCPMC9667315
OpenAlexW4308921417

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.